121 related articles for article (PubMed ID: 7589204)
1. kappa-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse.
Ukai M; Shinkai N; Kameyama T
Eur J Pharmacol; 1995 Aug; 281(2):173-8. PubMed ID: 7589204
[TBL] [Abstract][Full Text] [Related]
2. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
Ukai M; Itoh J; Kobayashi T; Shinkai N; Kameyama T
Behav Brain Res; 1997 Feb; 83(1-2):169-72. PubMed ID: 9062678
[TBL] [Abstract][Full Text] [Related]
3. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Itoh J; Ukai M; Kameyama T
J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
[TBL] [Abstract][Full Text] [Related]
4. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice.
Itoh J; Ukai M; Kameyama T
Brain Res; 1993 Aug; 619(1-2):223-8. PubMed ID: 8397052
[TBL] [Abstract][Full Text] [Related]
5. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.
Hiramatsu M; Kameyama T
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):595-9. PubMed ID: 9819804
[TBL] [Abstract][Full Text] [Related]
6. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of dynorphin A-(1-13) markedly improves cycloheximide-induced amnesia in mice.
Ukai M; Shan-Wu X; Kobayashi T; Kameyama T
Eur J Pharmacol; 1996 Oct; 313(1-2):11-5. PubMed ID: 8905323
[TBL] [Abstract][Full Text] [Related]
8. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
9. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
10. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice.
Itoh J; Ukai M; Kameyama T
Eur J Pharmacol; 1993 Jun; 236(3):341-5. PubMed ID: 8102969
[TBL] [Abstract][Full Text] [Related]
11. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
12. Involvement of kappa-opioid and sigma receptors in short-term memory in mice.
Hiramatsu M; Hoshino T; Kameyama T; Nabeshima T
Eur J Pharmacol; 2002 Oct; 453(1):91-8. PubMed ID: 12393064
[TBL] [Abstract][Full Text] [Related]
13. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Funada M; Suzuki T; Narita M; Misawa M; Nagase H
Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
[TBL] [Abstract][Full Text] [Related]
14. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
Diop L; Rivière PJ; Pascaud X; Junien JL
Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
[TBL] [Abstract][Full Text] [Related]
15. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.
Privette TH; Terrian DM
Psychopharmacology (Berl); 1995 Apr; 118(4):444-50. PubMed ID: 7568631
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance.
Itoh J; Ukai M; Kameyama T
Eur J Pharmacol; 1993 Sep; 241(1):99-104. PubMed ID: 7901037
[TBL] [Abstract][Full Text] [Related]
17. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
Wall PM; Messier C
Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
[TBL] [Abstract][Full Text] [Related]
18. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
Ukai M; Kameyama T
Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
[TBL] [Abstract][Full Text] [Related]
19. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
Touzeau PL; Shea-Donohue T
J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
